The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what Peptides in 2026, What the FDA Review Means Olympia Pharmaceuticals FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of Peptides got reclassified the moment they started threatening real revenue. Not because new safety data emerged. Not because patients started getting hurt. The moment pharma noticed people were healing tendons, sleeping better,
Shopping security
Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols
product description
Why choose thelockerguy wholesale?
Show More
fda 503a bulks list bpc-157 category 2 The FDA didn't “bring peptides back.” It opened a formal docket. And that distinction matters. This is not a blanket approval. Not a wellness free-for-all. Not one announcement that changes everything overnight